Jamison Private Wealth Management Inc. Sells 159 Shares of The Clorox Company (NYSE:CLX)

Jamison Private Wealth Management Inc. decreased its position in The Clorox Company (NYSE:CLX) by 6.5% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 2,306 shares of the company’s stock after selling 159 shares during the period. Jamison Private Wealth Management Inc.’s holdings in Clorox were worth $376,000 as of its most recent filing with the SEC.

Several other hedge funds have also recently modified their holdings of CLX. Vanguard Group Inc. lifted its holdings in Clorox by 0.3% during the first quarter. Vanguard Group Inc. now owns 15,277,580 shares of the company’s stock worth $2,339,150,000 after acquiring an additional 48,632 shares during the period. Nuance Investments LLC raised its stake in shares of Clorox by 150.6% during the 2nd quarter. Nuance Investments LLC now owns 1,597,674 shares of the company’s stock worth $218,035,000 after purchasing an additional 960,094 shares during the period. Van ECK Associates Corp boosted its holdings in shares of Clorox by 1,715.5% in the 2nd quarter. Van ECK Associates Corp now owns 1,461,207 shares of the company’s stock worth $199,411,000 after buying an additional 1,380,724 shares during the last quarter. Bank of New York Mellon Corp grew its position in Clorox by 14.4% during the second quarter. Bank of New York Mellon Corp now owns 961,387 shares of the company’s stock valued at $131,200,000 after buying an additional 120,716 shares during the period. Finally, Acadian Asset Management LLC increased its holdings in Clorox by 26.5% during the first quarter. Acadian Asset Management LLC now owns 882,526 shares of the company’s stock worth $135,099,000 after buying an additional 184,847 shares during the last quarter. Institutional investors own 78.53% of the company’s stock.

Clorox Price Performance

Shares of NYSE:CLX opened at $163.34 on Wednesday. The Clorox Company has a 12 month low of $114.68 and a 12 month high of $169.09. The company has a current ratio of 1.03, a quick ratio of 0.63 and a debt-to-equity ratio of 5.04. The stock has a market cap of $20.28 billion, a P/E ratio of 84.63, a P/E/G ratio of 3.19 and a beta of 0.41. The company has a 50 day moving average of $158.14 and a 200 day moving average of $144.85.

Clorox (NYSE:CLX) last issued its quarterly earnings data on Thursday, August 1st. The company reported $1.82 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.54 by $0.28. Clorox had a return on equity of 281.12% and a net margin of 3.95%. The company had revenue of $1.90 billion for the quarter, compared to the consensus estimate of $1.97 billion. As a group, sell-side analysts forecast that The Clorox Company will post 6.64 EPS for the current fiscal year.

Clorox Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, November 7th. Investors of record on Wednesday, October 23rd will be paid a $1.22 dividend. This represents a $4.88 dividend on an annualized basis and a yield of 2.99%. The ex-dividend date of this dividend is Wednesday, October 23rd. Clorox’s dividend payout ratio is currently 252.85%.

Analyst Ratings Changes

A number of research analysts have weighed in on CLX shares. JPMorgan Chase & Co. boosted their target price on shares of Clorox from $148.00 to $174.00 and gave the company a “neutral” rating in a research note on Friday, October 11th. Evercore ISI reduced their price objective on Clorox from $140.00 to $139.00 and set an “underperform” rating for the company in a report on Monday. Wells Fargo & Company decreased their target price on Clorox from $135.00 to $130.00 and set an “underweight” rating for the company in a research report on Wednesday, July 10th. TD Cowen began coverage on Clorox in a research report on Tuesday, July 23rd. They set a “sell” rating and a $122.00 price target on the stock. Finally, BNP Paribas upgraded Clorox to a “strong sell” rating in a research note on Friday, September 6th. Six analysts have rated the stock with a sell rating, nine have assigned a hold rating and one has issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $150.14.

Insider Buying and Selling at Clorox

In other news, EVP Angela C. Hilt sold 1,733 shares of the firm’s stock in a transaction on Friday, September 6th. The shares were sold at an average price of $165.52, for a total transaction of $286,846.16. Following the sale, the executive vice president now owns 13,471 shares in the company, valued at approximately $2,229,719.92. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. 0.51% of the stock is currently owned by company insiders.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.